- Home
- Companies
- usa new york
- clinical study
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Food and Beverage
- Agriculture
- University / Academia / Research
- Metal
- Pulp & Paper
- Waste and Recycling
- Water and Wastewater
- Air and Climate
- Government
- Energy
- Forestry & Wood
- Glassware
- Packaging
- Plastics & Resins
- Oil, Gas & Refineries
- Health and Safety
- Publishing / Media / Marketing
- Construction & Construction Materials
Clinical Study Suppliers In Usa New York
32 companies found
based inSchiedlberg, AUSTRIA
g.tec medical engineering produces invasive and non-invasive brain-computer interfaces (BCIs) and neurotechnology that are used worldwide to measure and analyze brain waves with the highest possible resolution. A key factor is the real-time data ...
based inNew York, NEW YORK (USA)
The mission of the Doris Duke Charitable Foundation is to improve the quality of people's lives through grants supporting the performing arts, environmental conservation, medical research and child well-being, and through preservation of the ...
based in, NEW YORK (USA)
'Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug ...
based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
based inNew York, NEW YORK (USA)
Roar Biomedical was established in 1997, and is located in New York City at Columbia University’s Audubon Biomedical Center. Roar supports drug discovery and clinical research by bringing new technologies to market, as well as through a variety of ...
based inBedford Hills, NEW YORK (USA)
“Education is our foundation.” This is the principle upon which industry pioneer, Peter Brunelli, founded Universal Imaging Inc in 1974. Peter recognized that training and education were imperative for any imaging equipment to consistently perform ...
based inNew York, NEW YORK (USA)
SIGA Technologies, Inc. is a public, commercial-stage pharmaceutical company focused on providing solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological, and nuclear ...
based inAndover, MASSACHUSETTS (USA)
Caliber I.D. is a global leader in the design and manufacture of confocal microscopy equipment for clinical and scientific research. Headquartered in Andover, MA with design and manufacturing in Rochester, NY, Caliber I.D is a medical technologies ...
based inSeattle, WASHINGTON (USA)
window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet the worldwide demand for immunosequencing technology. Over the past decade, we have developed our proprietary ...
based inD.N Hevel Eilot, ISRAEL
Algatech was founded in 1998 at Kibbutz Ketura. It was started as a pilot plant to commercialize cultivation techniques developed by Professor Boussiba at Ben Gurion University, a leading microalgae research institute – a relationship the company ...
based inFarmingdale, NEW YORK (USA)
We aim to have our proprietary procedural solutions become the standard of care and enhance patient outcomes throughout the world. We are doing that by building off our best in class surgical ultrasonic technology to change patient outcomes in ...
based inNew York City, NEW YORK (USA)
Founded in 2008, S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain. ...
based inNew York, NEW YORK (USA)
We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we seek to capitalize on ...
based inShirley, NEW YORK (USA)
BOC Sciences is a brand of BOCSCI Inc. We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals. ...
based inBuffalo, NEW YORK (USA)
KSL Biomedical companies specialize in translational medicine impacting immunology, Oncology and Genomics. KSL can provide a full suite of regulatory, quality, clinical consulting and contract research organization ...
based inVernon Hills, ILLINOIS (USA)
Cole-Parmer, an Antylia Scientific company, is a trusted global leader in laboratory essentials. We deliver a portfolio of reliable equipment and consumables to help speed scientific discovery in life sciences, clinical, academic and research ...
based inSyracuse, NEW YORK (USA)
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet technology is a ...
based inLondon, UNITED KINGDOM
Informa is a leading business intelligence, academic publishing, knowledge and events business, operating within the Knowledge and Information Economy. We serve commercial, professional and academic communities in many different sectors by helping ...
based inPort Chester, NEW YORK (USA)
For over 25 years, OMNi-BiOTiC® has been a leading professional probiotic brand in Europe. In 2019, our dedicated team based in New York introduced Omni-Biotic to the United States. Our targeted Omni-Biotic blends developed for stress, immunity, ...
This 3-month OMNi-BiOTiC® probiotic program is designed to reset the gut microbiome and support overall wellness. Based on over 30 years of gut microbiome research and 100+ clinical studies, this program is ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary ...